VNDA
Vanda Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$411.32M
P/E Ratio
—
EPS
$-3.74
Beta
0.71
52W High
$9.94
52W Low
$3.81
50-Day MA
$7.53
200-Day MA
$6.07
Dividend Yield
—
Profit Margin
-102.00%
Forward P/E
86.96
PEG Ratio
2.23
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia.
Fundamentals
| Revenue (TTM) | $216.10M |
| Gross Profit (TTM) | $203.06M |
| EBITDA | $-143.06M |
| Operating Margin | -70.50% |
| Return on Equity | -50.90% |
| Return on Assets | -16.50% |
| Revenue/Share (TTM) | $3.67 |
| Book Value | $5.54 |
| Price-to-Book | 1.25 |
| Price-to-Sales (TTM) | 1.90 |
| EV/Revenue | 0.727 |
| EV/EBITDA | 0.76 |
| Quarterly Earnings Growth (YoY) | -95.90% |
| Quarterly Revenue Growth (YoY) | 7.60% |
| Shares Outstanding | $60.13M |
| Float | $53.17M |
| % Insiders | 6.16% |
| % Institutions | 71.85% |
Historical Volatility
HV 10-Day
38.80%
HV 20-Day
39.67%
HV 30-Day
68.39%
HV 60-Day
106.46%
HV Rank
52.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($15.50 target)
4
Buy1
HoldData last updated: 4/29/2026